CytomX Therapeutics Azioni (NASDAQ: CTMX)

CytomX Therapeutics (NASDAQ:CTMX) Azioni, Quote.MetaTitle.unusual-options

CytomX Therapeutics

CytomX Therapeutics Inc

Assembly Biosciences, Inc. - Common Stock

Assembly Biosciences

Astria Therapeutics

Compass Therapeutics, Inc. - Common Stock

Compass Therapeutics

Corvus Pharmaceuticals, Inc. - Common Stock

Corvus Pharma

Erasca

Evommune

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

Geron

Gossamer Bio

Gyre Therapeutics

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

Inventiva S.A. - American Depository Shares

Inventiva

KalVista Pharmaceuticals, Inc. - Common Stock

KalVista Pharmaceuticals

Lexeo Therapeutics

MeiraGTx Hldgs

MapLight Therapeutics, Inc. - Common Stock

MapLight Therapeutics

Myriad Genetics

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals

Prime Medicine

Prothena Corporation plc - Ordinary Shares

Prothena Corp

RAPT Therapeutics

Replimune Group

Regenxbio

Rigel Pharmaceuticals, Inc. - Common Stock

Rigel Pharmaceuticals

Vir Biotechnology

CytomX Therapeutics (CTMX) Previsione

Notizie

Utili

Quote.Nav.option-chain

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Comments

CytomX Therapeutics Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO